FdaApplication
BLA 761339
Identifiers
- fda_app_no: BLA761339
Properties
| Property | Value |
|---|---|
| applicant_name | Regeneron Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2023-08-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VEOPOZ | POZELIMAB-BBFG | 400MG/2ML (200MG/ML) | Injection |
1 product